Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,260 | 23,700 | 16,040 | 12,490 | 7,740 |
| Marketable Securities | 25,430 | 24,550 | 30,030 | 69,040 | 27,170 |
| Receivables | 65,230 | 43,170 | 34,500 | 74,840 | 15,090 |
| Inventories | 37,250 | 17,760 | 11,570 | 16,330 | 5,360 |
| Other current assets | 6,530 | 11,060 | 4,260 | 3,730 | 1,700 |
| TOTAL | $161,700 | $120,240 | $96,400 | $176,430 | $57,060 |
| Non-Current Assets | |||||
| PPE Net | 19,910 | 16,530 | 14,030 | 21,680 | 9,950 |
| Other Non-Current Assets | 243,900 | 153,360 | 101,320 | 132,840 | 19,760 |
| TOTAL | $263,810 | $169,890 | $115,350 | $154,520 | $29,710 |
| Total Assets | $425,530 | $290,130 | $211,770 | $330,960 | $86,790 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 790 | 10,080 | 2,700 | 3,200 | 2,220 |
| Accounts payable and accrued liabilities | 57,950 | 41,740 | 37,990 | 42,550 | 15,130 |
| Other current liabilities | 0 | 2,120 | 790 | 39,690 | 0 |
| TOTAL | $62,200 | $60,030 | $43,990 | $132,230 | $17,360 |
| Non-Current Liabilities | |||||
| Long Term Debt | 135,740 | 32,700 | 10,830 | 9,960 | 6,710 |
| Other Non-Current Liabilities | 106,970 | 55,780 | 59,070 | 30,710 | 11,910 |
| TOTAL | $253,790 | $130,140 | $77,460 | $88,380 | $18,620 |
| Total Liabilities | $316,000 | $190,190 | $121,470 | $220,630 | $36,000 |
| Shareholders' Equity | |||||
| Common Shares | 130,340 | 157,240 | 134,320 | 153,570 | 62,990 |
| Retained earnings | -43,220 | -65,440 | -52,270 | -44,860 | -12,320 |
| Other shareholders' equity | 11,940 | 8,130 | 2,900 | 770 | 110 |
| TOTAL | $109,530 | $99,930 | $90,300 | $110,330 | $50,780 |
| Total Liabilities And Equity | $425,530 | $290,120 | $211,770 | $330,960 | $86,780 |